WILDTBVAC
Integrated solutions for Tuberculosis control in animals combining vaccination and multi-species diagnostics
| Coordinatore | NEIKER-INSTITUTO VASCO DE INVESTIGACION Y DESARROLLO AGRARIO SA
Organization address
address: BERREAGA KALEA 1 contact info |
| Nazionalità Coordinatore | Spain [ES] |
| Totale costo | 1˙560˙900 € |
| EC contributo | 998˙204 € |
| Programma | FP7-KBBE
Specific Programme "Cooperation": Food, Agriculture and Biotechnology |
| Code Call | FP7-KBBE-2013-7-single-stage |
| Funding Scheme | CP-TP |
| Anno di inizio | 2013 |
| Periodo (anno-mese-giorno) | 2013-12-01 - 2015-11-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
NEIKER-INSTITUTO VASCO DE INVESTIGACION Y DESARROLLO AGRARIO SA
Organization address
address: BERREAGA KALEA 1 contact info |
ES (DERIO) | coordinator | 131˙735.00 |
| 2 |
PRIONICS AG
Organization address
address: WAGISTRASSE 27 A contact info |
CH (SCHLIEREN) | participant | 195˙800.00 |
| 3 |
INMUNOLOGIA Y GENETICA APLICADA SA
Organization address
address: Hermanos Garcia Noblejas 41 contact info |
ES (MADRID) | participant | 160˙100.00 |
| 4 |
VACUNEK SL
Organization address
address: BERREAGA KALEA 1 contact info |
ES (DERIO) | participant | 153˙160.00 |
| 5 |
UNIVERSIDAD DE CASTILLA - LA MANCHA
Organization address
address: CALLE ALTAGRACIA 50 contact info |
ES (CIUDAD REAL) | participant | 101˙568.00 |
| 6 |
ISTITUTO SUPERIORE DI SANITA
Organization address
address: Viale Regina Elena 299 contact info |
IT (ROMA) | participant | 94˙160.00 |
| 7 |
UNIVERSIDAD COMPLUTENSE DE MADRID
Organization address
address: AVENIDA DE SENECA 2 contact info |
ES (MADRID) | participant | 88˙000.00 |
| 8 |
THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS
Organization address
address: Area 1A, Nobel House, Smith Square 17 contact info |
UK (LONDON) | participant | 73˙681.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Recent studies have showed estimations of worldwide 50 million cattle infections with M. bovis, at a cost to the agricultural community of 2-3 billion € per year. In developing countries, M. bovis infection is still widespread, in both cattle and humans. Even in developed countries, successful eradication of disease from livestock is hampered by the presence of wildlife reservoirs of M. bovis. Under these circumstances, a single case of a reportable disease in livestock can result in serious economic consequences for the producer, public, and governments. Within this scenario, there’s room and clear business opportunities for integrated control products or solutions that aim at addressing what is considered a global problem, animal tuberculosis. Our overall objective is therefore to take the results of the TB-STEP project - “Strategies for the eradication of bovine tuberculosis”, funded under FP7-KBBE-2007 with project number 212414, where most of the WildTBVac partners were involved, and build a pre-commercial set of TB control solutions by means of testing the technical and economical viability of the aforementioned integrated approach. WildTBVac specific objectives are the following: • To standardize and optimize the production of a TB Vaccine (prototype resulting of the TB-STEP project) • To evaluate several vaccine-compatible diagnostic strategies (also resulting from the TB-STEP project) that will include multi-species DIVA tests (wild boar, domestic pigs, cattle) • To assess the field efficacy of integrated TB control strategies including oral vaccination for TB control in wild boar • To evaluate the field efficacy of integrated TB control strategies including oral vaccination for TB control in domestic and feral pigs • To define the exploitation and commercialization strategy including clear technology transfer approaches and development of a market oriented business.'